A New Specific Succinate-Glutamate Metabolomic Hallmark in Sdhx-Related Paragangliomas

Succinate: A New Epigenetic Hacker

(2013) Ming Yang et al.   CANCER CELL

SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma

(2013) Eric Letouzé et al.   CANCER CELL

Influence of Metabolism on Epigenetics and Disease

(2013) William G. Kaelin et al.   CELL

Genotype-Specific Abnormalities in Mitochondrial Function Associate with Distinct Profiles of Energy Metabolism and Catecholamine Content in Pheochromocytoma and Paraganglioma

(2013) J. U. Rao et al.   CLINICAL CANCER RESEARCH

Metabolomic profile of the adrenal gland: from physiology to pathological conditions

(2013) Alessio Imperiale et al.   ENDOCRINE-RELATED CANCER

MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

(2012) N. Burnichon et al.   CLINICAL CANCER RESEARCH

Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma

(2012) Mariam Jafri et al.   CLINICAL ENDOCRINOLOGY

Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients

(2012) Valentina Piccini et al.   ENDOCRINE-RELATED CANCER

Inhibition of  -KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors

(2012) M. Xiao et al.   GENES & DEVELOPMENT

HMDB 3.0—The Human Metabolome Database in 2013

(2012) David S. Wishart et al.   NUCLEIC ACIDS RESEARCH

SDHA Immunohistochemistry Detects GermlineSDHAGene Mutations in Apparently Sporadic Paragangliomas and Pheochromocytomas

(2011) Esther Korpershoek et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy

(2011) Whitney B. Pope et al.   JOURNAL OF NEURO-ONCOLOGY

Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome

(2011) Z. J. Reitman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma

(2010) G. Eisenhofer et al.   ENDOCRINE-RELATED CANCER

Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes

(2010) Anthony J. Gill et al.   HUMAN PATHOLOGY

High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues

(2010) Olaf Beckonert et al.   Nature Protocols

Clinical aspects of SDHx-related pheochromocytoma and paraganglioma

(2009) Henri J L M Timmers et al.   ENDOCRINE-RELATED CANCER

An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis

(2009) Francien H van Nederveen et al.   LANCET ONCOLOGY

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

(2009) Lenny Dang et al.   NATURE

The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas

(2009) Judith Favier et al.   PLoS One

Bioinformatic methods in NMR-based metabolic profiling

(2009) Timothy M.D. Ebbels et al.   PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY

Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine

(2008) Hui Huang et al.   CANCER

High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer

(2008) Beathe Sitter et al.   PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY